UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-8A
NOTIFICATION OF REGISTRATION FILED PURSUANT TO SECTION 8(a) OF THE
INVESTMENT COMPANY ACT OF 1940
The undersigned investment company hereby notifies the Securities and Exchange Commission that it registers under and pursuant to the provisions of Section 8(a) of the Investment Company Act of 1940, and in connection with such notification of registration... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO SECTION 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2024
Commission File Number: 001-39950
Evaxion Biotech A/S
(Exact Name of Registrant as Specified in Its Charter)
Dr. Neergaards Vej 5f
DK-2970... (continue reading...)
April 2024
Preliminary Pricing Supplement No. 1,613
Registration Statement Nos. 333-275587; 333-275587-01
Dated March 29, 2024
Filed pursuant to Rule 424(b)(2)
Morgan Stanley Finance LLC
Structured Investments
Opportunities in U.S. Equities
Contingent Income Auto-Callable... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDERSECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 333-267203
Opti-Harvest, Inc.
(Exact name of registrant as specified in its charter)
190 N Canon Dr., Suite... (continue reading...)
More SEC Filings
View Older Stories-
Form NT 10-K Bannix Acquisition Corp. For: Dec 31
-
Form ABS-EE Benchmark 2023-B39 Mortg For: Mar 15
-
Form 8-K Gannett Co., Inc. For: Mar 29
-
Form 6-K ROYAL BANK OF CANADA For: Mar 29
-
Form 10-K Enservco Corp For: Dec 31
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 MORGAN STANLEY
-
Form 8-K Sphere 3D Corp. For: Mar 18
-
Form 10-D Citigroup Commercial For: Mar 15
-
Form MA-A David Taussig & Associat For: Dec 31
-
Form D/A Assurified, Inc.
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: RAJKOWSKI E MARK
-
Form ABS-EE Citigroup Commercial For: Mar 15
-
Form 424B2 MORGAN STANLEY
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Monteagudo Graciela
-
Form S-8 KALA BIO, Inc.
-
Form PRE 14A Merus N.V. For: May 07
-
Form D Synergist Technology,
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Lombardi Ronald M.
-
Form 10-D BENCHMARK 2022-B35 MORTG For: Mar 15
-
Form DEFA14A BRIGHTCOVE INC
-
Form ABS-EE BENCHMARK 2022-B35 MORTG For: Mar 15
-
Form 10-K/A PepGen Inc. For: Dec 31
-
Form DEF 14A BRIGHTCOVE INC For: May 08
-
Form ARS PAPA JOHNS INTERNATIONAL For: Dec 31
-
Form MA-A Argent Advisors, Inc. For: Dec 31
-
Form 424B2 BofA Finance LLC
-
Form ARS BRIGHTCOVE INC For: Dec 31
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Kroeger Thomas
-
Form 15-12G CURO Group Holdings Corp
-
Form 6-K SatixFy Communications For: Mar 29
-
Form 10-K KALA BIO, Inc. For: Dec 31
-
Form 4 ACCO BRANDS Corp For: Mar 27 Filed by: Keller Robert J
-
Form SC 13D/A Genetron Holdings Ltd Filed by: Wang Sizhen
-
Form 8-K AILERON THERAPEUTICS For: Mar 25
-
Form ARS AXCELIS TECHNOLOGIES For: Dec 31
-
Form ARS CHARLES RIVER LABORATORI For: Dec 30
-
Form D Fairmount Healthcare
-
Form 20-F SatixFy Communications For: Dec 31
-
Form PRE 14A Gannett Co., Inc. For: Jun 03
-
Form NT 10-K VNUE, Inc. For: Dec 31
-
Form 8-K KALA BIO, Inc. For: Mar 29
-
Form DEF 14A AXCELIS TECHNOLOGIES For: May 09
-
Form DEF 14A PAPA JOHNS INTERNATIONAL For: May 02
-
Form NT 10-K Adorbs Inc For: Dec 31
-
Form NT 10-K Winvest Group Ltd For: Dec 31
-
Form DEF 14A CHARLES RIVER LABORATORI For: May 08
-
Form NT 10-K Viveon Health Acquisitio For: Dec 31
-
Form 10-K TANCHENG GROUP CO., LTD. For: Dec 31
-
Form 8-K Ensysce Biosciences, For: Mar 29